סרטיקן ® 0.25 מ"ג טבליות מסיסות

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

EVEROLIMUS 0.25 MG

Disponible desde:

NOVARTIS PHARMA SERVICES AG

Código ATC:

L04AA18

formulario farmacéutico:

TABLETS DISPERSIBLE

Vía de administración:

PER OS

Fabricado por:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Grupo terapéutico:

EVEROLIMUS

indicaciones terapéuticas:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Fecha de autorización:

2010-02-01